Cholinergic signals regulate acute myeloid leukemia and chemotherapy response
This study reveals that autonomic cholinergic signaling drives acute myeloid leukemia progression and chemoresistance through a dual mechanism involving direct activation of leukemic cells via nicotinic receptors and indirect induction of stem cell quiescence in the bone marrow niche, suggesting that targeting this pathway could improve AML treatment outcomes.